Clinical Trial Update: Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels [Phase 2]

View source ↗

Summary

Phase 2 trial comparing abiraterone acetate plus ADT to apalutamide to both in advanced prostate cancer with non-castrate testosterone; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ADT (androgen deprivation therapy)
• Abiraterone acetate (Abiraterone acetate)
• Apalutamide (apalutamide)

Snippet

Sponsor: Latin American Cooperative Oncology Group | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED